Health TrialsbyHealthPanel

Assessing the Effectiveness of Screening, Brief Intervention, and Referral to Treatment (SBIRT) With Personalized Feedback Intervention to Reduce Polysubstance Impaired Driving in Young Adults Aged 18-30

ConditionImpaired Driving
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-30
SponsorUniversity of Washington

About this trial

The current study is assessing the effects of receiving Screening, Brief Intervention and Referral to Treatment alone versus also receiving a brief online personalized intervention on impaired driving behaviors among Washington State young adults aged 18-30.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18-30 at enrollment

Received Screening, Brief Intervention, and Referral to Treatment (SBIRT) in the past 3 month

Through SBIRT screened at moderate or moderate-to-high risk based on substance use OR reported any impaired driving the past 6 months

Lives in Washington State

Disqualifiers

Not meeting eligibility criteria

Inability to confirm participant's identity, residency, or date received SBIRT.

Trial design

Design model

Crossover

Treatments tested in this trial

  • Personalize Feedback Intervention

    Behavioral

    The brief online personalized feedback intervention (PFI) is adapted from the personalized feedback provided in BASICS, iCHAMP, studies using similar standalone PFI approaches. Specifically, feedback adapted from these brief motivational interventions and prior projects include: Patterns of use: alcohol, cannabis, other drug, and polysubstance use frequency, alcohol and cannabis quantity and peak; Substance use norms; Expectancies of use of alcohol ; Estimates on money the participant spends on alcohol and cannabis compared; Protective behavioral strategies; Alcohol- and/or cannabis-impaired driving norms; Wait time to drive and related psychoeducation; Additional psychoeducation is provided (e.g., standard drink; information on tetrahydrocannabinol (THC) percentages) throughout the feedback to improve understanding and motivation for change.

Treatment groups

600 Participants
are divided into 2 treatment groups
Group A: Waitlist controlActive comparator 1 intervention
Group B: Active InterventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Number of times in the past 3 months participants drove impaired by both alcohol and cannabis at 3 month follow-up

Time frame
From baseline to 3 months later at 3 month follow up assessment.

Secondary outcomes

1

Number of times in the past 3 months participants drove impaired by both alcohol and cannabis at 6 month follow-up

Time frame
From 3 month after completing baseline to 3 months later at the 6 month follow-up assessment
2

Number of times in the past 3 months participants drove impaired by alcohol only at 3 month follow-up

Time frame
From baseline to 3 months later at 3 month follow-up assessment
3

Number of times in the past 3 months participants drove impaired by cannabis only at 3 month follow-up

Time frame
From baseline to 3 months later at 3 month follow-up assessment
4

Number of times in the past 3 months participants drove impaired by alcohol only at 6 month follow-up

Time frame
From 3 months after baseline to 3 months later at 6 month follow-up assessment

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Washington

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: